Close

A note on cookies

We use cookies to improve your experience of our website. If you want to find out more see our Privacy Policy

UK Cilia Network

People menu

Dr John Sayer

MB ChB PhD FRCP FHEA

Senior Clinical Lecturer in Nephrology

Department  Institute of Genetic Medicine
  Newcastle University
Telephone  +44 191 241 8608
Email  john.sayer@newcastle.ac.uk
Homepage  http://research.ncl.ac.uk/epithelia/

Research Keywords

CEP290, nephronophthisis, cystic kidney disease

Research Interests

A paradigm states that all genes which are mutated in cystic kidney disease express their protein products in the primary cilia/basal body/centrosome. This implicates the primary cilium and its signalling pathways in the pathophysiology of kidney cyst formation.

Nephronophthisis, which literally means a wasting away of nephrons, is an autosomal recessive cystic kidney disease, which leads to end-stage renal failure within the first three decades of life. Originally described in 1951, its pathophysiology remained a mystery for over 45 years. Linkage studies have now identified several genes involved in nephronophthisis, most recently NPHP6 and AHI1, genes mutated in nephronophthisis associated with retinal degeneration and cerebellar vermis aplasia (Joubert syndrome). The “nephrocystin” proteins all colocalise to renal cilia or centrosome. Despite numerous genetic discoveries however, the mechanisms of disease remain unsolved. A role for nephrocystin proteins may also exist at cell-cell junctions and focal adhesion complexes, perhaps in maintaining planar cell polarity.

A potential clue is that all cystic kidney diseases present with decreased urinary concentration ability and that vasopressin V2 receptor antagonists have been successfully used in some rodent models of cystic kidney disease. In order to understand these processes further we are exploring models of disease to mimic the disease in kidney. These include functional epithelial cell models, developmental models involving Danio rerio and murine knockout models. Funding for these experiments has been generously provided by GlaxoSmithKline, as part of a Clinician Scientist fellowship to Dr. Sayer, the MRC, Kids Kidney Research, Northern Counties Kidney Research Fund and Kidney Research UK.

TBC

TBC

^ Back to Top